Treatment with MMS (1 mM, 4 h) also resulted in a significant increase > 2.5-fold (p < 0.05) in RECQ1 mRNA in MCF7 cells (breast cancer) similar to U2OS cells but not in HeLa (cervical carcinoma) cells (Figure 1C). This evidence concerns the gene RECQL and breast cancer.